Get the Stockscreener App
2.85
2.89%
0.08
Abvc Biopharma Inc stock is traded at $2.85, with a volume of 56,326.
It is up +2.89% in the last 24 hours and down -3.06% over the past month.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
See More
Previous Close:
$2.77
Open:
$2.72
24h Volume:
56,326
Relative Volume:
0.16
Market Cap:
$67.09M
Revenue:
$152.40K
Net Income/Loss:
$-10.52M
P/E Ratio:
-1.1432
EPS:
-2.4931
Net Cash Flow:
$-4.26M
1W Performance:
+7.55%
1M Performance:
-3.06%
6M Performance:
+309.42%
1Y Performance:
+312.92%
1-Day Range:
$2.72
$2.86
1-Week Range:
$2.63
$2.86
52-Week Range:
$0.40
$5.48
Abvc Biopharma Inc Stock (ABVC) Company Profile
Name
Abvc Biopharma Inc
Sector
Industry
Phone
510-668-0881
Address
44370 OLD WARM SPRINGS BLVD., FREMONT
Compare ABVC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABVC
Abvc Biopharma Inc
|
2.85 | 63.09M | 152.40K | -10.52M | -4.26M | -2.4931 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Abvc Biopharma Inc Stock (ABVC) Latest News
Understanding ABVC BioPharma Inc.’s price movementMarket Movers & Advanced Swing Trade Entry Plans - Newser
Can technical indicators confirm ABVC BioPharma Inc.’s reversalMarket Activity Report & Weekly Chart Analysis and Guides - Newser
Using fundamentals and technicals on ABVC BioPharma Inc.Chart Signals & Entry Point Confirmation Alerts - Newser
Risk vs reward if holding onto ABVC BioPharma Inc.2025 Market Sentiment & Real-Time Stock Price Movement Reports - Newser
How moving averages guide ABVC BioPharma Inc. tradingBull Run & Accurate Trade Setup Notifications - Newser
Live market analysis of ABVC BioPharma Inc.Portfolio Profit Report & Real-Time Volume Trigger Notifications - Newser
How to manage a losing position in ABVC BioPharma Inc.2025 Breakouts & Breakdowns & Free Expert Verified Stock Movement Alerts - Newser
Can you recover from losses in ABVC BioPharma Inc.July 2025 Trends & Technical Analysis for Trade Confirmation - Newser
Long term hold vs stop loss in ABVC BioPharma Inc.CEO Change & Low Risk High Win Rate Picks - Newser
Published on: 2025-09-12 13:42:13 - Newser
Real time breakdown of ABVC BioPharma Inc. stock performanceEarnings Growth Summary & Fast Exit/Entry Strategy Plans - Newser
Tools to assess ABVC BioPharma Inc.’s risk profileGlobal Markets & Stock Timing and Entry Methods - Newser
is abvc biopharma inc. stock entering bullish territoryJuly 2025 Short Interest & Weekly Top Gainers Alerts - Newser
ABVC BioPharma (NASDAQ:ABVC) Shares Up 2.6%Still a Buy? - MarketBeat
Will ABVC BioPharma Inc. stock recover after recent dropGap Up & Consistent Profit Focused Trading Strategies - Newser
How to monitor ABVC BioPharma Inc. with trend dashboardsEntry Point & Entry Point Confirmation Alerts - Newser
Visualizing ABVC BioPharma Inc. stock with heatmaps2025 Short Interest & Growth Oriented Trading Recommendations - Newser
ABVC BioPharma Inc. stock outlook for YEARJuly 2025 Closing Moves & Reliable Breakout Forecasts - Newser
Is ABVC BioPharma Inc. stock entering bullish territoryWeekly Profit Summary & Fast Gaining Stock Reports - Newser
Historical volatility pattern of ABVC BioPharma Inc. visualizedJuly 2025 Catalysts & Entry and Exit Point Strategies - Newser
Risk adjusted return profile for ABVC BioPharma Inc. analyzedMarket Performance Report & Free Long-Term Investment Growth Plans - Newser
Using RSI to spot recovery in ABVC BioPharma Inc.New Guidance & Real-Time Market Trend Scan - Newser
ABVC BioPharma Inc. stock momentum explainedWeekly Profit Report & AI Powered Market Trend Analysis - Newser
News impact scoring models applied to ABVC BioPharma Inc.Market Performance Recap & Advanced Technical Signal Analysis - Newser
Is ABVC BioPharma Inc. stock bottoming outJuly 2025 Big Picture & Accurate Intraday Trading Signals - Newser
using python tools to backtest abvc biopharma inc. strategiesTrade Entry Report & Short-Term Trading Opportunity Alerts - Newser
Can ABVC BioPharma Inc. expand into new marketsPortfolio Risk Report & High Accuracy Trade Signal Alerts - 뉴스영
What indicators show strength in ABVC BioPharma Inc.Quarterly Market Review & Real-Time Sentiment Analysis - Newser
What moving averages say about ABVC BioPharma Inc.Weekly Gains Report & Risk Controlled Swing Alerts - Newser
Statistical indicators supporting ABVC BioPharma Inc.’s strengthMarket Rally & Free Risk Controlled Daily Trade Plans - Newser
How hedge fund analytics apply to ABVC BioPharma Inc. stockJuly 2025 Sector Moves & Risk Managed Trade Strategies - Newser
Abvc Biopharma Inc Stock (ABVC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):